0001209191-19-059037.txt : 20191204
0001209191-19-059037.hdr.sgml : 20191204
20191204160826
ACCESSION NUMBER: 0001209191-19-059037
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191202
FILED AS OF DATE: 20191204
DATE AS OF CHANGE: 20191204
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Howarth Alex G.
CENTRAL INDEX KEY: 0001795798
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38137
FILM NUMBER: 191268272
MAIL ADDRESS:
STREET 1: C/O AKCEA THERAPEUTICS, INC.
STREET 2: 22 BOSTON WHARF ROAD, 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001662524
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 472608175
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 617-207-0202
MAIL ADDRESS:
STREET 1: 22 BOSTON WHARF RD
STREET 2: 9TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-12-02
0
0001662524
AKCEA THERAPEUTICS, INC.
AKCA
0001795798
Howarth Alex G.
C/O AKCEA THERAPEUTICS, INC.
22 BOSTON WHARF ROAD, 9TH FLOOR
BOSTON
MA
02210
0
1
0
0
Chief Operating Officer
Common Stock
2019-12-02
4
A
0
50000
0.00
A
50000
D
Stock Option (right to buy)
17.94
2019-12-02
4
A
0
300000
0.00
A
2029-12-01
Common Stock
300000
300000
D
The shares vest as follows: 25% of the shares vest on December 2, 2020 and then in equal monthly installments over the next three years.
/s/ Joshua F. Patterson, Attorney-in-Fact
2019-12-04